218 related articles for article (PubMed ID: 11406733)
1. The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction.
Cohen M
J Thromb Thrombolysis; 2001 Apr; 11(2):171-4. PubMed ID: 11406733
[No Abstract] [Full Text] [Related]
2. Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non-Q-wave acute myocardial infarction.
Monrad ES
Am J Cardiol; 2000 Apr; 85(8A):2C-9C. PubMed ID: 10793174
[TBL] [Abstract][Full Text] [Related]
3. Fondaparinux versus enoxaparin in acute coronary syndromes.
Majure DT; Aberegg SK
N Engl J Med; 2006 Jun; 354(26):2829; author reply 2830. PubMed ID: 16807423
[No Abstract] [Full Text] [Related]
4. Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention.
Fox KA; Antman EM; Cohen M; Bigonzi F;
Am J Cardiol; 2002 Sep; 90(5):477-82. PubMed ID: 12208405
[TBL] [Abstract][Full Text] [Related]
5. [Low molecular weight heparin in the treatment of acute coronary syndromes without ST-segment elevation: unstable angina and non-Q-wave myocardial infarction].
Borja J; Olivella P
Med Clin (Barc); 2000 Nov; 115(15):583-6. PubMed ID: 11141394
[No Abstract] [Full Text] [Related]
6. New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarction.
Bates ER
Curr Cardiol Rep; 2007 Jul; 9(4):289-97. PubMed ID: 17601395
[TBL] [Abstract][Full Text] [Related]
7. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
Antman EM; McCabe CH; Gurfinkel EP; Turpie AG; Bernink PJ; Salein D; Bayes De Luna A; Fox K; Lablanche JM; Radley D; Premmereur J; Braunwald E
Circulation; 1999 Oct; 100(15):1593-601. PubMed ID: 10517729
[TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction.
Berkowitz SD; Stinnett S; Cohen M; Fromell GJ; Bigonzi F;
Am J Cardiol; 2001 Dec; 88(11):1230-4. PubMed ID: 11728348
[TBL] [Abstract][Full Text] [Related]
9. Heparin versus placebo for non-ST elevation acute coronary syndromes.
Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Magee K
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD003462. PubMed ID: 24972265
[TBL] [Abstract][Full Text] [Related]
10. Unfractionated and low-molecular-weight heparins in acute coronary syndromes: current recommendations.
Brener SJ
Cleve Clin J Med; 2000 Jan; 67(1):59-65. PubMed ID: 10645678
[TBL] [Abstract][Full Text] [Related]
11. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
Ferguson JJ; Antman EM; Bates ER; Cohen M; Every NR; Harrington RA; Pepine CJ; Theroux P;
Am Heart J; 2003 Oct; 146(4):628-34. PubMed ID: 14564315
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparins in ischemic heart disease.
Yan AT; Goodman SG
Curr Opin Cardiol; 2004 Jul; 19(4):309-16. PubMed ID: 15218388
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.
Magee KD; Sevcik W; Moher D; Rowe BH
Cochrane Database Syst Rev; 2003; (1):CD002132. PubMed ID: 12535430
[TBL] [Abstract][Full Text] [Related]
14. [Treatment strategy of unstable angina and non-ST-segment elevation myocardial infarction].
Zaliūnas R
Medicina (Kaunas); 2002; 38 Suppl 2():11-4. PubMed ID: 12560610
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic adjuncts for immediate transfer to the catheterization laboratory in patients with acute coronary syndromes.
Kereiakes DJ; Young J; Broderick TM; Shimshak TM; Abbottsmith CW
Am J Cardiol; 2000 Dec; 86(12B):10M-17M. PubMed ID: 11206013
[TBL] [Abstract][Full Text] [Related]
16. New approaches to diagnosis and management of unstable angina and non-ST segment elevation myocardial infarction: controversial data.
Borja J; Paz MA; Olivella P
Arch Intern Med; 2002 Feb; 162(4):485-6. PubMed ID: 11863490
[No Abstract] [Full Text] [Related]
17. Low-molecular-weight heparin in patients with non-ST-segment elevation acute coronary syndrome: role in the emergency department.
Goodman SG
J Emerg Med; 2000 Oct; 19(3 Suppl):3S-11S. PubMed ID: 11050378
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparins in the management of acute coronary syndromes.
Zed PJ; Tisdale JE; Borzak S
Arch Intern Med; 1999 Sep; 159(16):1849-57. PubMed ID: 10493315
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin.
Antman EM; Kereiakes DJ
J Invasive Cardiol; 2000 Dec; 12 Suppl E():E1-4;discussion E25-8. PubMed ID: 11156721
[TBL] [Abstract][Full Text] [Related]
20. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
